JPMorgan Got $400M Before Inovalon Sale, Del. Justices Hear

By Leslie A. Pappas · February 21, 2024, 5:39 PM EST

Inovalon didn't properly disclose that investors that bought the healthcare data company in 2021 paid $400 million in fees to its financial adviser, a JPMorgan unit, before the transaction, a reason...

To view the full article, register now.